COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,974 Articles (22,604 medRxiv, 8,370 bioRxiv)

Most recent first Previous |  Page 2006: Articles 20051-20060  | Next

3D8, a nucleic acid-hydrolyzing scFv, confers antiviral activity against SARS-CoV-2 and multiple coronaviruses in vitro
Lee, G., Budhathoki, S., Choi, H. S., Oh, K.-j., Lee, G.-Y., Ham, Y. K., Kim, Y. J., Lim, Y. R., Hoang, P. T., Lee, Y., Lim, S.-W., Kim, J.-M., Cho, S., Song, J.-W., Lee, S., Kim, W.-K.
10.1101/2020.11.25.398909 — Posted: 2020-11-25
SARS-CoV-2 utilizes a multipronged strategy to suppress host protein synthesis
Finkel, Y., Gluck, A., Winkler, R., Nachshon, A., Mizrahi, O., Lubelsky, Y., Zuckerman, B., Slobodin, B., Yahalom-Ronen, Y., Tamir, H., Ulitsky, I., Israely, T., Paran, N., Schwartz, M., Stern-Ginossar, N.
10.1101/2020.11.25.398578 — Posted: 2020-11-25
Evolutionary analysis of SARS-CoV-2 spike protein for its different clades
Pereson, M. J., Flichman, D., Martinez, A., Bare, P., Garcia, G., Di Lello, F.
10.1101/2020.11.24.396671 — Posted: 2020-11-25 Discussion: Onsite | Offsite
Double Lock of a Potent Human Monoclonal Antibody against SARS-CoV-2
Wang, X., Qin, C., Wang, Y., Rao, Z., Xie, L., Zhu, L., Deng, Y.-Q., Zhang, R.-r., Cui, Z., Sun, C.-Y., Fan, C.-F., Xing, X., Huang, W., Chen, Q., Zhang, N.-N., Ye, Q., Cao, T.-S., Wang, N., Wang, L., Cao, L., Wang, H., Kong, D., Ma, J., Luo, C., Zhang, Y., Nie, J., Sun, Y., Lv, Z., Shaw, N., Li, Q., Li, X.-F., Hu, J.
10.1101/2020.11.24.393629 — Posted: 2020-11-25
A Nasal Spray Solution of Grapefruit Seed Extract plus Xylitol Displays Virucidal Activity Against SARS-Cov-2 In Vitro
Ferrer, G. A., Betancour, A., Go, C. C., Vazquez, H., Westover, J. B., Cagno, V., Tapparel, C., Sanchez-Gonzalez, M. A.
10.1101/2020.11.23.394114 — Posted: 2020-11-25
Nurses' burnout and associated risk factors during the COVID-19 pandemic: a systematic review and meta-analysis
Galanis, P. A., Vraka, I., Fragkou, D., Bilali, A., Kaitelidou, D.
10.1101/2020.11.24.20237750 — Posted: 2020-11-25
Analytical and diagnostic performances of a high-throughput immunoassay for SARS-CoV-2 IgM and IgG
Padoan, A., Cosma, C., Zaupa, P., Plebani, M.
10.1101/2020.11.20.20235267 — Posted: 2020-11-24
Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections
Hellewell, J., Russell, T. W., The SAFER Investigators and Field study team, , The Crick COVID-19 Consortium, , CMMID COVID-19 Working Group, , Beale, R., Kelly, G., Houlihan, C., Nastouli, E., Kucharski, A. J.
10.1101/2020.11.24.20229948 — Posted: 2020-11-24
Ipomoeassin-F inhibits the in vitro biogenesis of the SARS-CoV-2 spike protein and its host cell membrane receptor
O'Keefe, S., Roboti, P., Duah, K. B., Zong, G., Schneider, H., Shi, W. Q., High, S.
10.1101/2020.11.24.390039 — Posted: 2020-11-24 Discussion: Onsite | Offsite
Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking
Schuller, M., Correy, G. J., Gahbauer, S., Fearon, D., Wu, T., Diaz, R. E., Young, I. D., Carvalho Martins, L., Smith, D. H., Schulze-Gahmen, U., Owens, T. W., Deshpande, I., Merz, G. E., Thwin, A. C., Biel, J. T., Peters, J. K., Moritz, M., Herrera, N., Kratochvil, H. T., QCRG Structural Biology Consortium, , Aimon, A., Bennett, J. M., Brandao Neto, J., Cohen, A. E., Dias, A., Douangamath, A., Dunnett, L., Fedorov, O., Ferla, M. P., Fuchs, M., Gorrie-Stone, T. J., Holton, J. M., Johnson, M. G., Krojer, T., Meigs, G., Powell, A. J., Rack, J. G. M., Rangel, V. L., Russi, S., Skyner, R. E., Smith, C. A., Soares, A. S., Wierman, J. L., Zhu, K., Jura, N., Ashworth, A., Irwin, J., Thompson, M. C., Gestwicki, J. E., von Delft, F., Shoichet, B. K., Fraser, J. S., Ahel, I.
10.1101/2020.11.24.393405 — Posted: 2020-11-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).